G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683 | -52.0% | 474,080 | -17.1% | 0.00% | -50.0% |
| Q2 2023 | $1,424 | +20.0% | 571,791 | +29.1% | 0.00% | 0.0% |
| Q1 2023 | $1,187 | -66.2% | 442,975 | -31.5% | 0.00% | -60.0% |
| Q4 2022 | $3,514 | -99.7% | 647,100 | +531.9% | 0.01% | +150.0% |
| Q3 2022 | $1,279,000 | -44.2% | 102,400 | -77.9% | 0.00% | -33.3% |
| Q2 2022 | $2,292,000 | -10.2% | 464,000 | +337.3% | 0.00% | 0.0% |
| Q1 2021 | $2,553,000 | +117.5% | 106,100 | +50.1% | 0.00% | +200.0% |
| Q1 2019 | $1,174,000 | +97.0% | 70,700 | +520.2% | 0.00% | 0.0% |
| Q3 2018 | $596,000 | -49.7% | 11,400 | -64.4% | 0.00% | 0.0% |
| Q2 2018 | $1,186,000 | 0.0% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,186,000 | – | 32,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |